I’ve said in the past that I’ve worked with CEOs of some major companies. For all the bragging about CCs happening ‘more than any other company’, I’ve yet to see anything produced out of them from Generex.

My expectation of a CEO is to be straightforward, taking care of the shareholders and doing everything possible for the company he / she is running to succeed.

I’ve not seen that so far in Generex. Information is always a what if scenario due to funding. This had gone on for months and months.

We get inaccurate information like the S1 was going to be filed right after the dividend for NGIO, only to discover another form has to be filed first which can delay filing a S1 up to 90 days.

We also get news Generex can tap into 40-70 million dollars for funding. Great, except they won’t, because stock price is to low. So, now they are trying to seek other funding while millions are sitting there.

Blame games all over on bad actors, the OTC, MM’s. Yet, in the end, it’s all on Joe and Generex, because if nothing produces, it doesn’t matter about OTC or MMs.

This is now all on Generex, 100%.

They need to make some major decisions and get going before everyone loses.